Halozyme Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amarin USD 156.94M 58.98M 2024-09
Amgen USD 11.97B 2.96B 2024-12
Baxter International USD 1.76B 344M 2024-12
Cytokinetics USD 94.86M 47.97M 2024-12
DBV Technologies USD 32.5M 4.51M 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Indivior 372M 53M 2025-03
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
MannKind USD 46.34M 16.03M 2024-12
Pfizer USD 1.04B 49M 2024-12
United Therapeutics USD 1.9B 202.7M 2025-03



Halozyme Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.